ArticleAnnals of medicine and surgery (2012)2025

Cobenfy (xanomeline-trospium): a breakthrough FDA-approved therapy redefining schizophrenia treatment.

Syed Mohsin Raza Bukhari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.